Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Takeda Faces First Trial Over Actos Diabetes Drug in L.A.
Bloomberg
Tue, 02/19/13 - 10:11 am
Tags:
Takeda, Actos, diabetes
Takeda Worried About Actos’s Cancer Link, Filing Shows
BusinessWeek
Sat, 02/16/13 - 12:22 pm
Tags:
type 2 diabetes, Takeda, diabetes, cancer, Actos
Furiex Rises on FDA Approval of Takeda Diabetes Medicine
Bloomberg
Mon, 01/28/13 - 10:47 am
Tags:
FDA, diabetes, Takeda, Furiex Pharmaceuticals, alogliptin
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Mon, 01/28/13 - 10:11 am
Tags:
Takeda, diabetes, Actos, FDA
FDA announces approval of three new drugs to treat Type 2 diabetes
examiner.com
Sun, 01/27/13 - 11:35 am
Tags:
type 2 diabetes, Takeda, diabetes, alogliptin, Furiex Pharmaceuticals
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Sun, 01/27/13 - 11:25 am
Tags:
Takeda, diabetes, type 2 diabetes, Actos, alogliptin, Furiex Pharmaceuticals
Affymax: Investor Darling In 2012 Now Has To Perform In 2013
Seeking Alpha
Mon, 01/21/13 - 11:42 am
Tags:
Takeda, Fresenius, Amgen, Affymax
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Tags:
Alnylam, Regulus, Isis Pharmaceuticals, SynaGeva BioPharma, Sarepta Therapeutics, Onyx, Celgene, Millennium, Takeda, Ariad Pharmaceuticals, Pharmacyclics, Astex
Takeda and Amylin terminate obesity compound co-development agreement
equities.com
Sat, 12/29/12 - 10:38 am
Tags:
Takeda, Amylin, obesity, weight loss
Takeda writes off its $1B obesity deal with Amylin
Fierce Biotech
Fri, 12/28/12 - 11:59 am
Tags:
Amylin, Takeda
Takeda Consultant Loses Two Whistleblower Suits
Pharmalot
Tue, 11/20/12 - 11:29 am
Tags:
Takeda, whistleblower lawsuits
Takeda to acquire Envoy in $140 million deal
Pharma Times, UK
Tue, 11/6/12 - 12:12 pm
Tags:
Takeda, Envoy Therapeutics, M&A
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie
Takeda to buy LigoCyte, signs pact with India's Advinus
Pharma Times, UK
Fri, 10/5/12 - 12:22 pm
Tags:
Takeda, LigoCyte, India, M&A, Advinus
Lundbeck, Takeda seek U.S. approval for antidepressant
Chicago Tribune, IL
Tue, 10/2/12 - 12:17 pm
Tags:
Takeda, Lundbeck, antidepressants, vortioxetine
Cashed Up Biotech Vanda Could Keep On Falling
Seeking Alpha
Wed, 09/5/12 - 10:44 am
Tags:
Vanda, Eli Lilly, Novartis, Bristol-Myers Squibb, Takeda
Merck's Blockbuster Drug Januvia And Its Competitors
Seeking Alpha
Tue, 08/28/12 - 10:54 am
Tags:
Merck, Januvia, diabetes, AstraZeneca, Bristol-Myers Squibb, JNJ, Novartis, Sanofi, Takeda
Takeda's Actos era ends with generic launches
Fierce Pharma
Sat, 08/18/12 - 04:02 pm
Tags:
Takeda, Actos, diabetes, type 2 diabetes, generics
Teva and Ranbaxy start selling lower-cost version of Takeda's type 2 diabetes drug Actos
Yahoo/AP
Fri, 08/17/12 - 11:23 am
Tags:
Teva Pharmaceuticals, Takeda, Ranbaxy, generics, diabetes, Actos
Watson sues FDA on generic diabetes drug ruling
Yahoo/Reuters
Wed, 08/15/12 - 11:10 am
Tags:
FDA, generics, Watson Pharmaceuticals, diabetes, Actos, Takeda

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.